Five years after my lymphoma diagnosis, life looks normal on the outside; however, the fear of recurrence and the reality of ...

Dr. Alexandra Zaleta discussed actionable steps that individuals can take to advocate for a more person-centered insurance ...

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during ...

I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for ...

Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone ...

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

Oluwole is an associate professor of medicine in the Division of Hematology Oncology, Department of Medicine, at Vanderbilt University Medical Center, where he specializes in the treatment of ...

Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...